Indegene Limited sees revenue surge by 8% with robust profit margin in Q2 FY25
Indegene Limited, a digital-first life sciences commercialization company, has reported an impressive financial performance for the quarter ending September 30, 2024. According to their latest announcement, the company saw an 8.0% year-over-year growth in revenue, reaching INR 6,868 million for Q2 FY25. This growth is attributed to significant traction with both large and mid-size pharmaceutical […]